Cytokine-mediated down-regulation of B cell activity in SLE: effects of interleukin-2 and transforming growth factor-beta

Abstract

We have recently reported that transforming growth factor-beta (TGF-b) co-stimulates interleukin-2 (IL-2) activated CD8/ T cells to down-regulate antibody production. In SLE, lymphocyte production of both IL-2 and TGF-b is decreased. Here we report that a brief treatment of PBMC from SLE patients with IL-2 and TGF-b can result in marked inhibition of spontaneous polyclonal IgG and autoantibody production. Peripheral blood mononuclear cells (PBMC) from 12 patients with active SLE were exposed to IL-2 with or without TGF-b for three days, washed and cultured for seven more days. The mean decrease in IgG secretion was 79%. The strongest inhibitory effect was observed in cases with the most marked B cell hyperactivity. Spontaneous production of anti-nucleoprotein (NP) antibodies was observed in four cases and cytokine treatment of PBMC decreased autoantibody production by 50–96%. IL-2 inhibited Ig production by either TGF-b-dependent or independent mechanisms in individual patients. In a study of anti-CD2 stimulated IgG production in a patient with active SLE, we documented that IL-2 and TGF-b reversed the enhancing effects of CD8/ T cells on IgG production and induced suppressive activity instead. These results raise the possibility that cytokine-mediated down-regulation of B cell hyperactivity in SLE may have therapeutic potential.

Keywords

cytokines systemic lupuserythematosus transforming growth factor-beta interleukin-2 B lymphocytes

Get full access to this article

View all access options for this article.

References

Hahn BH , An overview of the pathogenesis of systemic lupus erythematosus. Dubois' Lupus Erythematosus, Williams and Wilkins: Baltimore , 5th edn. 1997; pp 69–78.

Horwitz DA , Stohl W , Gray JD . T lymphocytes, natural killer cells, cytokines, and immuno regulation. Dubois' Lupus Erythematosus, Williams and Wilkins: Baltimore , 5th edn. 1997; pp 155–194.

Wahl SM . TGF beta: the good, the bad and the ugly . J Exp Med 1994; 180: 1587–1590 .

Gray JD , Hirokawa M , Ohtsuka K , Horwitz DA . Generation of an inhibitory circuit involving CD8 / T cells, IL-2, and NK cell-derived TGF-b, contrasting effects of anti-CD2 and anti-CD3 . J Immunol 1998; 160: 2248–2254 .

Ohtsuka K et al. Decreased production of transforming growth factor-beta by Lymphocytes from Patients with SLE . J Immunol 1998; 160: 2539–2545 .

Klinman DM et al. Quantitation of IgG and IgM secreting B cells in the peripheral blood of patients with systemic lupus erythematosus . Arthritis Rheum 1991; 34: 1404–1410 .

Shivakumar S , Tsokos GC , Datta SK . T cell receptor a/b expressing double-negative (CD4 7 =CD8 7) and CD4 / T helper cells in humans augment the production of pathogenic anti-DNA autoantibodies associated with lupus nephritis . J Immunol 1989; 143: 103–112 .

Linker-Israeli M , Quismorio FP , Horwitz DA . CD8 / lymphocytes from patients with systemic lupus erythematosus sustain, rather than suppress spontaneous polyclonal IgG production and synergize with CD4 / cells to support autoantibody synthesis . Arthritis Rheum 1990; 33: 1216–1225 .

Horwitz DA et al. The immunoregulatory effects of natural killer cells: the role of TGFb and implications for autoimmunity . Immunology Today 1998; 18: 538–542 .

10.

Tan EM et al. The 1982 revised criteria for the classification of systemic lupus erythematosus . Arthritis Rheum 1982; 25: 1271-1271 .

11.

Liang MH , Socher SA , Larson MG , Schur PH . Reliability and validity of six systemic for the clinical assessment of disease activity in systemic lupus erythematosus . Arthritis Rheum 1989; 32: 1107–1118 .

12.

Bombardier C et al. Derivation of the SLEDAI, a disease activity index for lupus patients . Arthritis Rheum 1992; 35: 630–640 .

13.

Llorente L et al. Spontaneous production of IL-10 by B lymphocytes and monocytes in systemic lupus erythematosus . Eur Cytokine Network 1993; 4: 421–427 .

14.

Jacob CO et al. Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor a: relevance to genetic predisposition to systemic lupus erythematosus . Proc Natl Acad Sci USA 1990; 87: 1233–1237 .

15.

Hirohata S , Davies LS , Lipsky PE . Role of IL-2 in the generation of CD4 / suppressors of human B cell responsiveness . J Immunol 1989; 142: 3104–3112 .

16.

Fast LD . Generation and characterization of IL-2 activated veto cells . J Immunol 1992; 149: 1510–1515 .

17.

Massague J . The transforming growth factor-b family . Annu Rev Cell Biol 1990; 6: 597–641 .

18.

Kehrl JH . Transforming growth factor-b: an important mediator or immunoregulation . Int J Cell Cloning 1991; 9: 438–450 .

19.

Flaumenhaft R , Kojima S , Abe M , Rifkin DB . Activation of latent transforming growth factor-b . Adv Pharmacol 1993; 24: 51–76 .

20.

Weiner HL et al. Oral tolerance:immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens 1 . Annu Rev Immunol 1994; 12: 809–837 .

21.

Neurath MF et al. Experimental granulomatous colitis in mice is abrogated by induction of TGF-b-mediated oral tolerance . J Exp Med 1996; 183: 2605–2516 .

22.

Letterio JJ , Roberts AB . Regulation of immune responses by TGF-beta . Ann Rev Immunol 1998; 16: 137–162 .

23.

Kehrl JH et al. Production of transforming growth factor b by human T lymphocytes and its potential role in the regulation of T cell growth . J Exp Med 1986; 163: 1037–1050 .

24.

Lee HM , Rich S . Differential activation of CD8 / T cells by transforming growth factor b1 . J Immunol 1993; 151: 668–677 .

25.

Van Vlasselaer P , Punnonen J , de Vries JE . Transforming growth factor-b directs IgA switching in human B cells . J Immunol 1992; 148: 2062–2067 .

26.

Gray JD , Hirokawa M , Horwitz DA . The role of transforming growth factor-b in the generation of suppression: an interaction between CD8 / T and NK cells . J Exp Med 1994; 180: 1937–1942 .

27.

Sadlack B et al. Generalized autoimmune disease in interleukin-2 deficient mice is triggered by uncontrolled activation and proliferation of CD4 / T cells . Eur J Immunol 1995; 25: 3053–3059 .

28.

Huang YP et al. Correlation of T and B cell activities in vitro and serum IL-2 levels in systemic lupus erythematosus . J Immunol 1998; 141: 827–833 .

29.

Coffman RL et al. The role of helper T cell products in mouse B cell differentiation and isotype regulation . Immunol Rev 1988; 102: 5–28 .

30.

Noble A , Zhao Z , Cantor H . Suppression of immune responses by CD8 / cells. II. Qa-1 activated B cells stimulates CD8 cell suppression of T helper 2 responses . J Immunol 1998; 160: 566–571 .

31.

Stohl W , Elliott JE , Lynch DH , Kiener PA . CD95 (Fas)-based, super-antigen-dependent, CD4 / T cell-mediated down-regulation of human in vitro immunoglobulin responses . J Immunol 1998; 160: 5231–5238 .

32.

Esser MT et al. IL-2 induces Fas ligand/Fas (CD95L/CD95) cytotoxicity in CD8 / and CD4 / T lymphocyte clones . J Immunol 1997; 158: 5612–5618 .

33.

Dauphinee MJ , Kipper SB , Wofsy D , Talal N . Interleukin 2 deficiency is a common feature of autoimmune mice . J Immunol 1981; 6: 2483–2487 .

34.

Sadlack B , Lohler J , Schorle H , Klebb G , Haber H , Sickel E , Noelle RJ , Horak I . Generalized autoimmune disease in interleukin-2-deficient mice is triggered by an uncontrolled activation and proliferation of CD4 / T cells . Eur J Immunol 1995; 11: 3053–3059 .

35.

Dang H , Geiser AG , Letterio JJ , Nakabayashi T , Kong L , Fernandes G , Talal N . SLE-like autoantibodies and Sjogrens syndrome-like lymphoproliferation in TGF-beta knockout mice . J Immunol 1995; 6: 3205–3212 .

36.

Gray JD , Horwitz DA . Activated human natural killer cells can stimulate resting B lymphocytes cells to secrete immunoglobulin . J Immunol 1995; 154: 5656–5664 .